サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1659392

尿路結石管理装置の世界市場

Urolithiasis Management Devices

出版日
ページ情報
英文 93 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
尿路結石管理装置の世界市場
出版日: 2025年02月20日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 93 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

尿路結石管理装置の世界市場は2030年までに28億米ドルに達する見込み

2024年に20億米ドルと推定される尿路結石管理装置の世界市場は、2030年には28億米ドルに達し、分析期間2024-2030年のCAGRは5.5%で成長すると予測されます。本レポートで分析したセグメントの1つである体外衝撃波結石破砕（ESWL）治療は、CAGR 5.3％を記録し、分析期間終了までに11億米ドルに達すると予測されます。体外結石破砕治療セグメントの成長率は、分析期間中CAGR 5.8％と推定されます。

米国市場は5億2,870万米ドル、中国はCAGR8.3％で成長予測

米国の尿路結石管理装置市場は、2024年に5億2,870万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを8.3%として、2030年までに6億2,890万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.3％と4.4％と予測されています。欧州では、ドイツがCAGR 4.0%で成長すると予測されています。

世界の尿路結石管理装置市場- 主要動向と促進要因のまとめ

尿路結石管理装置とは何か、なぜ腎結石の治療に不可欠なのか？

尿路結石管理装置は、腎臓、尿管、膀胱、尿道などの泌尿器系に結石が形成される尿路結石症の診断、管理、治療に使用される医療機器です。尿路結石症は一般に腎臓結石として知られ、放置すると激しい痛み、尿閉、腎臓損傷の可能性があります。これらの装置には、体外衝撃波結石破砕装置（ESWL）、尿管鏡、腎鏡、レーザー結石破砕装置、ステントなど、さまざまな技術が含まれ、尿路から腎結石を破壊、除去、または通過しやすくするように設計されています。これらの治療機器により、非侵襲的治療と低侵襲的治療の両方が可能となり、患者の転帰を改善し、回復時間を短縮することができます。

尿路結石管理装置の重要性は、世界中で数百万人が罹患している一般的な健康状態に対処する能力にあります。食習慣、脱水、肥満、特定の病状などの要因が腎結石の発生に関与しており、腎臓の健康を維持するためには効果的な管理が不可欠です。感染症、腎不全、再発性結石などの合併症を予防するためには、早期診断と適時の治療が不可欠です。尿路結石管理装置は、結石の大きさ、組成、位置に基づいて治療計画を調整するためのツールをヘルスケア専門家に提供し、腎結石管理に対する患者中心のアプローチを提供します。尿路結石の発生率が世界的に上昇を続ける中、これらの機器は、効果的で安全かつ効率的な治療を保証する上で重要な役割を果たしています。

技術の進歩は尿路結石管理装置市場をどのように形成しているか？

技術の進歩により、尿路結石管理装置の精度、有効性、安全性が大幅に向上し、腎臓結石治療のイノベーションが推進されています。最も注目すべき開発のひとつは、体外衝撃波結石破砕術（ESWL）の改良です。これは非侵襲的な技術であり、集束衝撃波を用いて腎結石を自然に通過できる小さな破片に砕く。最新のESWL装置には、リアルタイム画像、結石の位置特定機能の向上、患者の位置決め機能が搭載されており、成功率の向上、治療時間の短縮、患者の快適性の向上につながっています。さらに、電磁式および圧電式結石破砕装置の進歩により、ESWL装置の精度とエネルギー供給が向上し、結石の破砕効率が向上しています。

低侵襲手術では、尿管鏡と腎鏡のデザイン、柔軟性、画像処理機能が大きく進歩しました。高精細な画像を提供するデジタル尿管鏡の開発により、尿路結石の検出、標的、除去が改善されました。小型化され柔軟性のある尿管鏡は、到達困難な結石へのアクセスを可能にすると同時に、周辺組織への外傷を最小限に抑え、回復時間を短縮しています。レーザー結石破砕術もまた、高パルスレート、調節可能なパルス幅、二波長技術を提供するホルミウムレーザーシステムの使用などの技術革新により、進化を遂げています。これらの進歩により、特に硬い結石や大きな結石に対して、より効率的に結石を破砕することが可能になり、手技をよりよく制御できるようになり、安全性が向上しました。

もう一つの重要な進歩は、複雑な腎結石除去症例に対するロボット支援手術器具の使用です。ロボット技術は、より高い精度、制御、器用さを提供し、経皮的腎結石除去術（PCNL）やその他の侵襲的手技の治療成績を向上させる。さらに、薬剤溶出性ステントや生分解性ステントなどの改良されたステントデザインは、術後のケア管理に役立ち、尿管閉塞や感染症などの合併症を減少させる。このような技術革新は、尿路結石管理装置の能力を拡大するだけでなく、入院期間とヘルスケアコストを削減する低侵襲で患者に優しい治療を目指す幅広い動向とも一致しています。

様々なヘルスケアにおける尿路結石管理装置の新たな用途とは？

尿路結石管理装置は、腎臓結石の有病率の増加や治療方法の進歩により、様々なヘルスケアシーンで応用が広がっています。病院や泌尿器科専門センターでは、ESWL、尿管鏡検査、経皮的腎結石除去術（PCNL）などの手技をサポートし、診断と治療の両方の目的で広く使用されています。泌尿器科医は、結石の正確な位置確認、効果的な破砕、完全な除去を確実に行い、患者の転帰を改善し、再発率を低下させるために、高度な画像診断システムとレーザーシステムに依存しています。これらの機器は外来手術センターでも重要であり、そこでは小さな結石を治療するために低侵襲手術がしばしば行われるため、当日退院や早期回復が可能になります。

救急医療の現場では、ハンドヘルド超音波診断装置やポータブル画像診断ツールが、急性尿路結石症例の迅速な診断と評価に不可欠となっており、適切な治療のための迅速な意思決定を可能にしています。遠隔医療プラットフォームはまた、初期評価とフォローアップケアのための遠隔診察と診断機能を統合し、尿路結石症管理への幅広いアクセスを支援しています。プライマリ・ケアや診療所では、超音波や高度尿分析キットなどの非侵襲的診断ツールが結石形成の早期発見に使用され、専門医へのタイムリーな紹介を容易にし、緊急介入の必要性を減らしています。さらに、在宅医療環境では、ウェアラブルセンサーやデジタルヘルスアプリが、水分補給、食事摂取、潜在的な結石症状をモニターするために使用され、患者が尿路結石症を予防的に管理するのに役立っています。ヘルスケアの分散化と患者中心主義が進む中、尿路結石管理装置の用途は拡大しており、さまざまなケア環境における多様なヘルスケアニーズに対応する汎用性を反映しています。

尿路結石管理装置市場の成長の原動力は？

尿路結石管理装置市場の成長は、腎臓結石の有病率の上昇、低侵襲治療の採用増加、診断・治療技術の進歩など、いくつかの要因によってもたらされます。主な成長要因の1つは、水分補給不足、高ナトリウム食、肥満、糖尿病や高血圧などの代謝性疾患などのライフスタイル要因に後押しされた尿路結石症例の世界の増加です。腎結石の発生率が高まるにつれ、効果的でタイムリーな管理ソリューションに対する需要が急増し、医療提供者にとって尿路結石管理装置は不可欠なツールとなっています。ESWL、尿管鏡検査、レーザー結石破砕術などの低侵襲処置に対する認識が高まっているため、患者や医療提供者は、回復が早く、痛みが少なく、合併症発生率が低い治療を好むようになり、これらの機器の採用がさらに進んでいます。

画像技術やレーザー技術の進歩も、市場の成長に重要な役割を果たしています。高精細デジタル尿管鏡、先進的な砕石器、AI駆動型診断ツールの開発により、腎結石治療の精度、安全性、効率が向上し、患者の転帰改善につながった。さらに、画像診断と診断におけるAIと機械学習の統合は、結石の検出、特徴づけ、治療計画を強化し、尿路結石症管理をより正確で個別化されたものにしています。より良い泌尿器科治療、医療アクセスの向上、腎結石の予防と管理に関する啓発キャンペーンを促進する政府の取り組みやヘルスケア政策が、市場の成長をさらに支えています。

外来手術センターや外来診療施設の増加も、尿路結石管理装置市場の成長に寄与しています。これらの施設では、費用対効果が高く効率的な治療が提供され、低侵襲治療への患者のアクセスが増加しています。遠隔モニタリング、食事指導、治療後のケアのための遠隔医療やデジタルヘルスツールの拡大により、尿路結石症管理はより包括的なものとなり、患者の積極的な病状管理をサポートしています。ヘルスケアシステムが患者中心の治療と高度な医療技術を優先し続ける中、治療における革新、医療意識の高まり、泌尿器科の転帰改善に対する世界の注目により、尿路結石管理装置の需要は拡大すると予想されます。

セグメント

治療タイプ（体外衝撃波結石破砕術（ESWL）、体腔内結石破砕術、経皮的腎結石破砕術、その他の治療タイプ）;エンドユース（病院・クリニック、外来手術センター）

調査対象企業の例（注目の合計42社）

  • Boston Scientific Corporation
  • Cook Medical, LLC
  • Dornier MedTech GmbH
  • Gimmi GmbH
  • KARL STORZ SE & Co. KG
  • Olympus America
  • Olympus Europa SE & Co. KG
  • Richard Wolf GmbH
  • Storz Medical AG
  • Walz Elektronik GmbH

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP23002

Global Urolithiasis Management Devices Market to Reach US$2.8 Billion by 2030

The global market for Urolithiasis Management Devices estimated at US$2.0 Billion in the year 2024, is expected to reach US$2.8 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2024-2030. Extracorporeal Shock Wave Lithotripsy (ESWL) Treatment, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Intracorporeal Lithotripsy Treatment segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$528.7 Million While China is Forecast to Grow at 8.3% CAGR

The Urolithiasis Management Devices market in the U.S. is estimated at US$528.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$628.9 Million by the year 2030 trailing a CAGR of 8.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Urolithiasis Management Devices Market - Key Trends & Drivers Summarized

What Are Urolithiasis Management Devices, and Why Are They So Crucial in Treating Kidney Stones?

Urolithiasis Management Devices are medical tools and equipment used to diagnose, manage, and treat urolithiasis, which is the formation of stones in the urinary system, including the kidneys, ureters, bladder, and urethra. Urolithiasis, commonly known as kidney stones, can cause severe pain, urinary blockages, and potential kidney damage if left untreated. These devices encompass a range of technologies, including extracorporeal shock wave lithotripsy (ESWL) machines, ureteroscopes, nephroscopes, laser lithotripters, and stents, which are designed to break down, remove, or facilitate the passage of kidney stones from the urinary tract. The devices allow for both non-invasive and minimally invasive treatment options, improving patient outcomes and reducing recovery times.

The importance of urolithiasis management devices lies in their ability to address a prevalent health condition that affects millions of individuals worldwide. Factors like dietary habits, dehydration, obesity, and certain medical conditions contribute to the development of kidney stones, making effective management crucial for maintaining renal health. Early diagnosis and timely treatment are essential to prevent complications such as infection, renal failure, and recurrent stone formation. Urolithiasis management devices provide healthcare professionals with tools to tailor treatment plans based on stone size, composition, and location, offering a patient-centric approach to kidney stone management. As the incidence of urolithiasis continues to rise globally, these devices play a critical role in ensuring effective, safe, and efficient treatment.

How Are Technological Advancements Shaping the Urolithiasis Management Devices Market?

Technological advancements have significantly enhanced the precision, efficacy, and safety of Urolithiasis Management Devices, driving innovation in kidney stone treatment. One of the most notable developments is the improvement in Extracorporeal Shock Wave Lithotripsy (ESWL), a non-invasive technique that uses focused shock waves to break kidney stones into smaller fragments that can be passed naturally. Modern ESWL devices are equipped with real-time imaging, improved stone localization, and patient positioning features, leading to higher success rates, reduced treatment times, and greater patient comfort. Additionally, advancements in electromagnetic and piezoelectric lithotripters have increased the precision and energy delivery of ESWL devices, enhancing stone fragmentation efficiency.

In minimally invasive procedures, ureteroscopes and nephroscopes have seen significant advancements in design, flexibility, and imaging capabilities. The development of digital ureteroscopes, which offer high-definition visualization, has improved the detection, targeting, and removal of stones in the urinary tract. Miniaturized and flexible ureteroscopes enable access to difficult-to-reach stones while minimizing trauma to surrounding tissues, reducing recovery times. Laser lithotripsy has also evolved, with innovations such as the use of holmium laser systems that offer high pulse rates, adjustable pulse widths, and dual-wavelength technology. These advancements allow for more efficient stone fragmentation, particularly in harder or larger stones, and provide better control over the procedure, enhancing safety.

Another key advancement is in the use of robotic-assisted surgical tools for complex cases of kidney stone removal. Robotic technologies offer greater precision, control, and dexterity, improving outcomes in percutaneous nephrolithotomy (PCNL) and other invasive procedures. Additionally, improved stent designs, such as drug-eluting and biodegradable stents, help in managing post-operative care, reducing complications like ureteral obstruction and infection. These technological innovations not only expand the capabilities of urolithiasis management devices but also align with broader trends toward minimally invasive, patient-friendly treatments that reduce hospital stays and healthcare costs.

What Are the Emerging Applications of Urolithiasis Management Devices Across Different Healthcare Settings?

Urolithiasis Management Devices are finding expanding applications across various healthcare settings, driven by the increasing prevalence of kidney stones and advancements in treatment modalities. In hospitals and specialized urology centers, these devices are widely used for both diagnostic and therapeutic purposes, supporting procedures like ESWL, ureteroscopy, and percutaneous nephrolithotomy (PCNL). Urologists rely on advanced imaging and laser systems to ensure accurate stone localization, effective fragmentation, and complete removal, improving patient outcomes and reducing recurrence rates. These devices are also critical in outpatient surgical centers, where minimally invasive procedures are often performed to treat smaller stones, allowing for same-day discharge and faster recovery.

In emergency care settings, handheld ultrasound devices and portable imaging tools are becoming essential for rapid diagnosis and assessment of acute urolithiasis cases, enabling quick decision-making for appropriate treatment. Telemedicine platforms are also integrating diagnostic capabilities with remote consultation for initial assessment and follow-up care, supporting broader access to urolithiasis management. In primary care and clinics, non-invasive diagnostic tools like ultrasound and advanced urine analysis kits are used to detect stone formation early, facilitating timely referral to specialists and reducing the need for emergency interventions. Additionally, in-home care settings, wearable sensors and digital health apps are being used to monitor hydration, dietary intake, and potential stone symptoms, helping patients manage urolithiasis proactively. As healthcare becomes more decentralized and patient-centric, the applications of urolithiasis management devices are expanding, reflecting their versatility in addressing diverse healthcare needs across different care settings.

What Drives Growth in the Urolithiasis Management Devices Market?

The growth in the Urolithiasis Management Devices market is driven by several factors, including the rising prevalence of kidney stones, increasing adoption of minimally invasive treatments, and advancements in diagnostic and therapeutic technologies. One of the primary growth drivers is the global rise in urolithiasis cases, fueled by lifestyle factors such as poor hydration, high-sodium diets, obesity, and metabolic conditions like diabetes and hypertension. As the incidence of kidney stones increases, the demand for effective and timely management solutions has surged, making urolithiasis management devices essential tools for healthcare providers. The growing awareness of minimally invasive procedures, such as ESWL, ureteroscopy, and laser lithotripsy, has further driven the adoption of these devices, as patients and providers prefer treatments that offer faster recovery, reduced pain, and lower complication rates.

Advancements in imaging and laser technologies have also played a significant role in the market’s growth. The development of high-definition digital ureteroscopes, advanced lithotripters, and AI-driven diagnostic tools has improved the accuracy, safety, and efficiency of kidney stone treatment, leading to better patient outcomes. Additionally, the integration of AI and machine learning in imaging and diagnostics is enhancing stone detection, characterization, and treatment planning, making urolithiasis management more precise and personalized. Government initiatives and healthcare policies that promote better urological care, increased healthcare access, and awareness campaigns about kidney stone prevention and management have further supported market growth.

The rise of outpatient surgical centers and ambulatory care facilities has also contributed to the growth of the urolithiasis management devices market. These settings offer cost-effective and efficient treatments, increasing patient access to minimally invasive procedures. The expansion of telehealth and digital health tools for remote monitoring, dietary guidance, and post-treatment care has made urolithiasis management more comprehensive, supporting patients in managing their condition proactively. As healthcare systems continue to prioritize patient-centered care and advanced medical technologies, the demand for urolithiasis management devices is expected to grow, driven by innovations in treatment, increasing healthcare awareness, and the global focus on improving urological outcomes.

SCOPE OF STUDY:

The report analyzes the Urolithiasis Management Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment Type (Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy, Other Treatment Types); End-Use (Hospitals & Clinics, Ambulatory Surgical Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Boston Scientific Corporation
  • Cook Medical, LLC
  • Dornier MedTech GmbH
  • Gimmi GmbH
  • KARL STORZ SE & Co. KG
  • Olympus America
  • Olympus Europa SE & Co. KG
  • Richard Wolf GmbH
  • Storz Medical AG
  • Walz Elektronik GmbH

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Urolithiasis Management Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Incidence of Kidney Stones Drives Demand for Urolithiasis Management Devices
    • Growing Preference for Non-Surgical Treatments Sets the Stage for Device Adoption
    • Integration of Laser Technologies in Treatment Drives Urolithiasis Device Market
    • Expanding Role of Extracorporeal Shock Wave Lithotripsy (ESWL) Boosts Market Demand
    • Increasing Adoption of Ultrasound Imaging Drives Urolithiasis Treatment Solutions
    • Push for Single-Use Devices to Prevent Infections Boosts Device Adoption
    • Case Overview: Growth in Urology Clinics Enhances Demand for Urolithiasis Devices
    • Growing Use of Robotics in Stone Management Sets the Stage for Device Adoption
    • Focus on Outpatient Stone Treatment Enhances Market Opportunities
    • Increasing Prevalence of Obesity Propels Urolithiasis Device Adoption
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Urolithiasis Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Urolithiasis Management Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Extracorporeal Shock Wave Lithotripsy (ESWL) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Extracorporeal Shock Wave Lithotripsy (ESWL) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Extracorporeal Shock Wave Lithotripsy (ESWL) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Intracorporeal Lithotripsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Intracorporeal Lithotripsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Intracorporeal Lithotripsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Percutaneous Nephrolithotomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Percutaneous Nephrolithotomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Percutaneous Nephrolithotomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Other Treatment Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Ambulatory Surgical Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Ambulatory Surgical Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Urolithiasis Management Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • JAPAN
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • CHINA
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • EUROPE
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Urolithiasis Management Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Urolithiasis Management Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • FRANCE
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • GERMANY
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Urolithiasis Management Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Urolithiasis Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • INDIA
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Urolithiasis Management Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Urolithiasis Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Urolithiasis Management Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Urolithiasis Management Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030
  • AFRICA
    • Urolithiasis Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Urolithiasis Management Devices by Treatment Type - Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Urolithiasis Management Devices by Treatment Type - Percentage Breakdown of Value Sales for Extracorporeal Shock Wave Lithotripsy (ESWL), Intracorporeal Lithotripsy, Percutaneous Nephrolithotomy and Other Treatment Types for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Urolithiasis Management Devices by End-Use - Hospitals & Clinics and Ambulatory Surgical Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Urolithiasis Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Clinics and Ambulatory Surgical Centers for the Years 2015, 2025 & 2030

IV. COMPETITION